AXNX - Company ID 0001603756
Axonics, Inc. trades as AXNX. This page tracks Axonics, Inc. through 481 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Over the last 6 fiscal years Axonics, Inc.'s revenue grew from $128.00K to $366.38M, a compound annual growth rate of 276.8%. Net profit margin expanded from -14110.2% to -1.7% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 15-12G | - | 2024-11-25 |
| EFFECT | - | 2024-11-20 |
| POS AM | - | 2024-11-15 |
| S-8 POS | - | 2024-11-15 |
| S-8 POS | - | 2024-11-15 |
| Major company event | 8-K | 2024-11-15 |
| Insider trade | 4 | 2024-11-15 |
| Insider trade | 4 | 2024-11-15 |
The largest companies sharing Axonics, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).